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Abstract 
Leukemia epitomizes the class of highly complex diseases that new technologies aim to tackle by 
using large sets of single-cell level information. Achieving such goal depends critically not only 
on experimental techniques but also on approaches to interpret the data. A most pressing issue is 
to identify the salient quantitative features of the disease from the resulting massive amounts of 
information. Here, I show that the entropies of cell-population distributions on specific 
multidimensional molecular and morphological landscapes provide a set of measures for the 
precise characterization of normal and pathological states, such as those corresponding to healthy 
individuals and acute myeloid leukemia (AML) patients. I provide a systematic procedure to 
identify the specific landscapes and illustrate how, applied to cell samples from peripheral blood 
and bone marrow aspirates, this characterization accurately diagnoses AML from just flow 
cytometry data. The methodology can generally be applied to other types of cell-populations and 
establishes a straightforward link between the traditional statistical thermodynamics 
methodology and biomedical applications.  
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I. INTRODUCTION 
Many complex diseases require the measurement of multiple molecular factors at the single-cell 
level over large populations of cells for their precise characterization and detailed understanding 
[1-3]. Current technologies, such as flow cytometry (FCM), allow for such measurements, 
including simultaneous quantification of several morphological and molecular properties [4,5]. 
These technologies can currently provide the simultaneous single-cell measurement of tens of 
surface and intracellular markers of up to thousands of cells per second [6,7]. Such rapid 
technological development, however, is yet to be matched by traditional analysis tools to 
interpret the data [8,9]. It is now clear that all this data by itself, without the analytical tools to 
extract the relevant information, is not enough to faithfully understand the underlying cellular 
processes and their dysregulation in diseases such as cancer. 
 A prototypical example in which large amounts of data are generated is the cytometric 
analysis of acute myeloid leukemia (AML), a type of cancer produced by the dysregulated 
growth of the myeloid line of blood cells [10]. AML leads to abnormal white blood cells, red 
blood cells, or platelets to accumulate in the bone marrow and blood, which interferes with the 
production of normal blood cells. The presence of abnormal cells can potentially be detected by 
analyzing the changes of the distribution of morphological and molecular attributes of cell 
samples from blood or bone marrow. There are important difficulties associated with this 
approach for diagnosing AML. Besides abnormal cells being mixed with normal cells in the 
population samples, there are several AML subtypes and there is not an obvious well-defined set 
of changes in the molecular attributes that can fully characterize AML. In addition, there is the 
natural variation between individuals that overlaps with the changes induced by AML. Thus, the 
main challenge is to identify the quantities that best can be used to distinguish between AML 
patients and Normal (AML-free) individuals based on the single-cell statistical properties of their 
blood or bone marrow cell populations. 
 Here, I show that entropy, as traditionally used in statistical thermodynamics [11], 
provides a measure for the precise diagnosis of AML. Cell populations are characterized by their 
entropies in multidimensional landscapes constructed from the distributions of single-cell 
morphological and molecular attributes of flow cytometry data. Diagnosis is achieved by 
comparing how far the cell population distribution of an individual is from the AML and Normal 
prototypical maximum-entropy distributions.  
 The approach presented here was applied to samples from peripheral blood and bone 
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marrow of 359 patients provided at the DREAM6/FlowCAP2 Molecular Classification of AML 
Challenge [9,12]. The results accurately diagnosed AML in a blind set of 179 patients from just 
the provided training set of 180 patients, and ranked first among the best performing methods of 
this challenge [9,13]. Challenges such as those put forth by DREAM (Dialogue for Reverse 
Engineering Assessments and Methods) and FlowCAP (Flow Cytometry: Critical Assessment of 
Population Identification Methods) provide objective unbiased evaluations of computational 
methods in complex situations and eliminate the possibility of overfitting since the results are not 
known in advance [9,14-16]. The different approaches that participated at the 
DREAM6/FlowCAP2 challenge included mostly traditional machine learning algorithms, such 
as Support Vector Machine Regression, Logistic Regression, Vector Quantization, and 
Correlative Matrix Mapping. Overall, most of the approaches obtained good results [9].  
 
II. GENERAL APPROACH 
Leukemia, as any other type of cancer, results from dysregulated growth caused by genetic and 
epigenetic changes that alter the cellular state [17]. Therefore, the first step towards 
distinguishing cancerous from normal cell populations is to characterize the state of each cell. To 
take into account that there is only limited information, the approach considers measured, x , and 
internal (non-measured), q , quantities separately. In the case of FCM, light scattering and the 
intensity of fluorescent reporters are the prototypical examples of measured quantities. Internal 
quantities are much more numerous and include, among others, non-measured protein levels and 
specific DNA mutations. The characterization of a population i  considers the probability 
distribution ( , )iP x q  of these two types of attributes among its cells. 
 The goal is to discriminate among different cell-population types based on the statistical 
properties of their measurable quantities. To be able to take into account the effects of the 
internal quantities q , one must estimate their effects from the measurable quantities x , which 
should carry sufficient information about the key cellular differences between the different 
population types.  
 A convenient starting point to estimate the effects of the internal quantities in a cell 
population is the entropy of its attributes distribution ( , ) ln ( , )i i iS P x q P x q dxdq= −∫ . This 
quantity can be expressed as a function of just x  by rewriting the join probability 
( , ) ( | ) ( )i i iP x q P q x P x=  in terms of the conditional probability of q  with respect to x , ( | )iP q x , 
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and the probability of x , ( )iP x . Integration over q  leads to  
 ( )( ( ) ln ( ))i i i iS P x f x P x dx= − +∫ , (1) 
which explicitly encapsulates the contributions from internal quantities into the function 
( ) ( | ) ln ( | )i i if x P q x P q x dq= ∫ .  
 The main hypothesis to proceed further is that the internal contribution for each 
population ( )if x  can accurately be approximated by the same function ( )Tf x  for all the 
members of a given type T . In the case of AML and Normal types, the result would be 
( ) ( )i AMLf x f x=  or ( ) ( )i Normalf x f x=  depending on whether the population i  is AML or Normal.  
 The function ( )Tf x  can be estimated by considering a reference maximum entropy 
distribution ( )TP x  that integrates the main features of the cell populations of the type T . The 
maximum condition implies that ( )( ( ) ln ( ))T T T TS P x f x P x dxδ δ= − +∫  is zero, which happens 
when the term multiplying the variation of the probability in the integrand is constant. This 
condition can be rewritten as ( ) ln ( )T T Tf x P x S= − − , where the constant TS  is the maximum 
entropy for the cell population type T . Therefore, using ( ) ( ) ln ( )i T T Tf x f x P x S= = − −  in Eq. (1) 
leads to 
 , ( ) ln( ( ) / ( ))i T T i i TS S P x P x P x dx−= ∫ , (2) 
which can be interpreted as the entropy of the population i  on the multidimensional 
morphological and molecular landscape defined by the maximum entropy distribution for the cell 
population type T .  
 The explicit reference distribution ( )TP x  is chosen as the distribution that maximizes the 
total entropy of all the members of the type T . The variation of the total entropy with respect to 
( )TP x  is given by ,( ) ( )( ( )) )(/i T T i Ti T i TS P x P x P dxxδ δ∈ ∈= −∑ ∑∫ , which is zero when ( )TP x  is 
proportional to ( )ii T P x∈∑ . Therefore,  ( )TP x  is chosen to be the average distribution, which for 
AML and Normal types is given by ( ) (1/ ) ( )AMAM L iLL i AMx N P xP ∈= ∑  and 
( ) (1/ ) ( )Normal Normal ii Normalx N P xP ∈= ∑ , respectively, where AMLN  and NormalN  are the number of 
cell populations for each type. 
 The explicit form of Eq. (2) shares many similarities with other expressions used in 
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physical sciences and in information theory. It has exactly the same form as the Gibbs entropy 
formula [11,18,19]. The main difference is that, in that case, the state T  refers to an equilibrium 
state instead of a cell population type. It is also very similar, except for the constant TS , to the 
Kullback-Leibler divergence, which uses relative entropies to compare distributions [20]. It is 
important to emphasize that entropy defined by Eq. (2) does not quantify variability. Instead, it 
quantifies how similar the distribution of measured values for a given individual is to the 
expected average distribution for a given type. High entropy means that the distribution of the 
individual is similar to the expected distribution and low entropy means that it is different. Both 
high and low variability would lead to low relative entropy values if the underlying distributions 
are not close to the expected distribution. 
 A key feature of the method is that since it is based on a maximum principle with respect 
to the distributions of the attributes, the effects of small perturbations in the measured 
distributions are second order and therefore they will only impact minimally the results.  
 The analogy with statistical thermodynamics can be extended further to estimate the 
likelihood ,i Tp  of the population's belonging to the type T  through the Einstein fluctuation 
formula, ,,  ~ i T
S
i Tp e , which relates the probability of observing a state with its entropy [21,22]. 
After normalization, it results in  
 
,
,,
i T
i T
S
i T S
T
ep
e ′
′
= ∑ , (3) 
where the sum in the denominator is performed over all the cell population types. This 
expression assigns a high likelihood to a cell population as being of type T  if the distribution of 
its attributes has a form similar to the maximum entropy distribution for that type. This 
assignment parallels in many ways the approach first used by A. Einstein to compute the 
probability of observing a fluctuation moving a system away from its equilibrium state based on 
its entropy change [22]. 
 
III. APPLICATION TO DIAGNOSING LEUKEMIA 
The explicit application to diagnosing AML relies on evaluating whether the distribution of the 
values of flow cytometry data for a given individual to be diagnosed (Fig. 1 and Supplementary 
Fig. 1) is closer to the AML or Normal maximum entropy distribution (Fig. 1). Using just a few 
variables, such as side scatter and a fluorescent marker for the receptor protein CD45, is 
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informative in many cases but does not offer a full characterization (compare for instance AML 
patient #7 with Normal patient #96 in Supplementary Fig. 1). In general, there are several sets of 
simultaneously measured variables for a given individual and therefore there are several different 
landscapes. For each population i  and each set k  of simultaneously measured variables kx , the 
corresponding entropy is given by , ( ) ln( ( ) / ( ))
k k k k k k
i T T i i TS S P x P x P x dx= − ∫ . For an AML 
individual, the values of the entropies are expected to be , 0
k k
i AML AMLS S− ≈  and 
, 0
k k
i Normal NormalS S− << . A Normal individual, in contrast, would lead to , 0
k k
i AML AMLS S− <<  and 
, 0
k k
i Normal NormalS S− ≈ . Therefore, the relative entropy difference  
 , , ( ) ln( ( ) / ( ))
k k k k k k k k k
i i Normal i AML Normal AML i AML NormalS S S S S P x P x P x dxΔ = − = − − ∫ , (4) 
indicates that the individual looks like an AML patient for negative values and like a Normal 
subject for positive values. These entropies can be used to compute the weighted entropy 
difference 
 ki k ikS w SΔ = Δ∑% , (5) 
where kw  is the weight of the set k . Similarly, the weighted entropies are defined by 
,,
k
i T k ik T
S w S=∑%  and kT k TkS w S=∑% . The likelihood for the population i  to be AML is estimated 
using Eq. (3) with the weighted entropy difference as  
 ,
1
1 ii AML S
p
eΔ
=
+
% . (6) 
 
IV. IMPLEMENTATION 
The DREAM6/FlowCAP2 data [9,12] consists of seven groups of measurements for each 
individual, each group comprising the simultaneous measurements of the forward scatter (FS), 
the side scatter (SS), a fluorescent marker for the receptor protein CD45 (FL3), and a different 
combination of four different fluorescent markers for other proteins (FL1, FL2, FL4, and FL5). 
The specific fluorescent markers used as FL1, FL2, FL4, and FL5 in each group of 
measurements are listed in Table I. Therefore, there are seven different attribute spaces, 
described by the seven-dimensional vectors x = (FS, SS, FL1, FL2, FL3, FL4, FL5). For each 
space, the entropy can be computed in the full seven dimensions or in any combination of 
subspaces.  
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 An avenue to estimate the suitability of a space or subspace for AML and Normal 
individual discrimination is to use leave-one-out cross-validation with the training data. In this 
case, it consists in testing each individual i  of the training set without its contribution to AMLP  or 
NormalP .  
 The results of cross-validation with uniform weights 1kw =  (Fig. 2 and Supplementary 
Fig. 2) indicate that Normal and AML populations have high and low iSΔ %  values respectively, as 
expected from the assumptions of the approach. Only the population samples of just a few AML 
individuals have higher iSΔ %  than the lowest iSΔ %  for the Normal set. Therefore, the assumption 
that the function ( )if x  can be approximated by the maximum entropy distribution of its type 
holds for the cell populations of most individuals. In general, it is observed that for higher 
dimensionality spaces, the number of AML individuals that overlap with Normal ones is smaller. 
Such a small overlap indicates that the entropy on multidimensional morphological and 
molecular landscapes provides an efficient avenue to discriminate AML from Normal 
populations.  
 The results with the test set, using AMLP  and NormalP  computed from the training set, show 
even better segregation of individuals based on the entropy of their cell-population samples (Fig. 
2 and Supplementary Fig. 2). It is possible to use Eq. (6) to estimate the likelihood for an 
individual of being AML positive. However, the values AMLS  and NormalS  for the maximum 
entropy of AML and Normal individuals are not readily available. A first approximation, based 
on the cross-validation results, is to consider 0AML NormalS S− ≈ . The results indicate that the 
approach accurately diagnoses AML, except for just a few individuals (Fig. 2 and Supplementary 
Fig. 2) and that the performance increases with the dimensionality of the space in which the 
entropy is computed. The results also suggest that the test data was easier to classify than the 
training data, which contains a few difficult patients. 
 The discriminative capabilities can be improved by selecting, among the many 
possibilities available, not only the dimensionality of the space but also the subspaces. The 
subspace can be chosen by selecting the weights kw  to be either 0 or 1. For instance, a 
combination that proved to give good results is the 4-dimensional distributions for the values of 
kx =  (FS, SS, FL3, k ) with k ∈ { FL1, FL2, FL4, FL5} for the seven groups of measurements. 
Taking into account that the markers denoted as FL1, FL2, FL4, and FL5 are different in each 
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group of measurements, there are 7 4 28× =  landscapes for each individual. The predictions 
obtained with this approach ranked first among the best performers of the DREAM6 competition 
(Supplementary Information). Further improvement can be achieved by adjusting the values of 
the weights to maximize the segregation between AML and Normal in the cross-validation 
phase. 
 A systematic procedure for adjusting the weights kw  in Eq. (5) to better segregate 
between AML and Normal individuals is to increase the weights that benefit the segregation and 
decrease the weights that worsen it. Segregation is quantified by the distance between the 
Normal, minN , and AML, maxA , individual with the minimum and maximum entropy difference, 
respectively. This distance is explicitly defined by kkkS w SΔΔ = ΔΔ∑% , with 
min max
k k k
i N i AS S S= =ΔΔ = Δ − Δ . The procedure considers updates proportional to a small quantity tΔ  
so that the weights at the step index t  are updated iteratively to the step index t t+ Δ  through the 
expression 
 ( )(1 )( )
( )(1 )
k
k
k k
kk
w t t Sw t t
w t t S
+ Δ ΔΔ
+ Δ =
+ Δ ΔΔ∑ . (7) 
This procedure guaranties that SΔΔ %  increases in each interaction if tΔ  is sufficiently small and 
the identities of the individuals minN  and maxA  do not change. Under these assumptions, 
expanding Eq. (7) in tΔ  and using 2 2( ) ( ) ( )kkS t S t w tΔΔ = ΔΔ∑ , leads to 
2( ) ( ) ( ( )) ( )k kkS t t S t t S S t w tΔΔ + Δ ≈ ΔΔ + Δ ΔΔ − ΔΔ∑% % , which shows that the increase is 
proportional to a combination of positive quantities. 
 The enhancement of the discrimination between AML and Normal individuals by 
adjusting the weights ( )kw t  according to Eq. (7) is illustrated by the values of the entropies of 
each population i  with respect to AML, ,i AML AMLS S−% % , and Normal, ,i Normal NormalS S−% % , states. For 
1kw = , AML and Normal populations tend to be separated according to their entropies but there 
is a significant overlap (Fig. 3a). By updating the weights kw  according to Eq. (7), the quantity 
SΔΔ % , which is negative, is increased by decreasing its absolute value. This quantity never 
changes to positive values and there is not an actual segregation of the populations (Fig. 3b). 
Closer inspection indicates that segregation is prevented by a patient in the AML training set 
 9
(patient #116 in Fig. 1). By removing this patient from the calculation of maxA , there is a clear 
segregation of AML and Normal individuals according to the entropies of their distributions 
(Fig. 3c). Perfect segregation occurs in both cross-validation with the training set, which was 
used to obtain the different parameters, and predictions with the test set, which is completely 
independent of the training set. As shown in Fig. 3c, the reason patient #116 prevented 
segregation is because this patient has the Normal instead of the typical AML signatures.  
 The segregation measure ( )S tΔΔ %  starting with 1kw =  increases with the number of 
iterations, as shown mathematically, until it reaches a plateau. In all the cases except for 7-D, it 
changes its sign from negative to positive values (Supplementary Fig. 3), implying that complete 
segregation has been achieved in the training set. This segregation, except for 7-D, is also present 
in the test set (Fig. 4 and Supplementary Fig. 4). In the 7-D case, ( )S tΔΔ %  remains negative, 
indicating that such a high dimensional space is not fully reliable for segregation based on 
entropies. By choosing AML NormalS S−% %  so that max min max( )( ) / 2 0k kk i N i Ak w t S S= =Δ + Δ =∑ , the 
approach correctly diagnoses the presence of AML in all the cases of the test set from one- to 
six- dimensions (Fig. 4 and Supplementary Fig. 4).  
 
V. DISCUSSION 
The use of physical approaches has been remarkably successful in the characterization of 
heterogeneous cell populations and their evolution in many complex biological scenarios [23-26] 
to the extent of making inroads in the mainstream biomedical research [27,28].  One of the main 
problems posed by hematological cancers, such as AML, is the underlying heterogeneity 
resulting from diverse molecular changes in the cellular state, including several recurrent 
mutations and chromosome translocations [10,17]. This heterogeneity is responsible to a large 
degree for the observed different clinical courses and is characterized at the cellular level by 
changes in size and granularity and by the acquisition and loss of characteristic cell surface 
markers. Traditional approaches to diagnose AML seek to identify subpopulations of cells with 
these characteristic changes induced by the disease [2,9].  
 The analysis presented here has shown that, despite the heterogeneity present, it is 
possible to define an average characterization of AML and Normal cell populations on 
multidimensional morphological and molecular landscapes that can be used to accurately 
diagnose the presence of this type of cancer. This approach shares many similarities with 
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traditional statistical thermodynamic methods that use entropy to collapse many nonmeasurable 
degrees of freedom within just a few key macroscopic or mesoscopic variables. In the case of 
cell populations, the quantities analogous to the macroscopic and mesoscopic variables are the 
combinations of attributes that define multidimensional morphological and molecular landscapes 
for each population type. This analogy establishes a straightforward link between statistical 
thermodynamics and biomedical applications and opens the door to the use of the sophisticated 
statistical physics methodology to tackle problems of direct medical importance.   
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TABLES 
 
TABLE I. List of the five specific fluorescent markers, denoted by FL1, FL2, FL3, FL4, and 
FL5, used in each of the 7 groups of measurements.  
 
Group FL1 FL2 FL3 FL4 FL5 
1 IgG1-FITC IgG1-PE CD45-ECD IgG1-PC5 IgG1-PC7 
2 Kappa-FIT Lambda-PE CD45-ECD CD19-PC5 CD20-PC7
3 CD7-FITC CD4-PE CD45-ECD CD8-PC5 CD2-PC7 
4 CD15-FITC CD13-PE CD45-ECD CD16-PC5 CD56-PC7
5 CD14-FITC CD11c-PE CD45-ECD CD64-PC5 CD33-PC7
6 HLA-DR-FITC CD117-PE CD45-ECD CD34-PC5 CD38-PC7
7 CD5-FITC CD19-PE CD45-ECD CD3-PC5 CD10-PC7
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FIGURE CAPTIONS 
 
FIG. 1 (color online). Molecular and morphological landscapes of leukemia. The two-
dimensional distribution of cells with given values of the logarithms of the side scatter (SS log) 
and the marker CD45 (CD45 log) intensities are shown for representative cell populations, with 
black and white colors representing high and zero densities, respectively. The distributions for 
AML patient #26 ( 26P ) and normal individual #4 ( 4P ) are indicative of distributions that closely 
resemble the maximum entropy distribution of their state, either AML ( AMLP ) or Normal ( NormalP ) 
states. The distribution for AML patient #116 ( 116P ), in contrast, does not show a clear 
discriminative feature of the presence of AML in the SS-CD45 landscape.  
 
FIG. 2 (color online). Entropy-based discrimination between AML and Normal individuals. The 
total relative entropy difference, using Eq. (5) with 1kw = , is shown for each individual of the 
training and test sets for two-, three-, and four-dimensional landscapes. The likelihood that an 
individual of the test set is AML positive, given by Eq. (6), is also shown for two-, three-, and 
four-dimensional landscapes. Circles and squares represent, respectively, the actual AML and 
Normal state of a patient as clinically assessed by a physician. The insets are magnifications 
around the AML-Normal boundary. 
 
FIG. 3 (color online). Total and weighted entropies on the two-dimensional landscapes defined 
by the maximum entropy distribution for AML and Normal states. The entropies for the training 
(left column) and test (right column) sets were computed from Eq. (5) with uniform kw  (a), with 
the kw  that maximize the distance SΔΔ %  of the training set (b), and with the kw  that maximize 
the distance SΔΔ %  of the training set excluding patient #116 (c). Circles and squares represent, 
respectively, the actual AML and Normal state of a patient as clinically assessed by a physician. 
The dashed lines are given by , , max( ) / 2Normal i Normal AML i AMLS S S S S t− = − + ΔΔ% % % % %  with the value of 
max( ) / 2S tΔΔ %  equal to 0 (a), -5.21 (b), and 8.15 (c). The black circle with the orange contour 
corresponds to the AML patient #116.  
 
FIG. 4 (color online). Weighted-entropy enhancement of the discrimination between AML and 
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Normal individuals. Same situation as in Fig. 2 but with the weights kw  that maximize the 
distance SΔΔ %  of the training set excluding patient #116. 
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Supplementary Information: Entropy of leukemia on 
multidimensional morphological and molecular landscapes 
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This Supplementary Information includes the details of the implementation of the Team21's solution 
to the DREAM6/FlowCAP2 Molecular Classification of Acute Myeloid Leukemia Challenge; the source 
code of two python files; and four supplementary figures. 
 
Team21's solution to the DREAM6/FlowCAP2 Molecular Classification of 
Acute Myeloid Leukemia Challenge 
The approach of team21, consisting of Jose M. G. Vilar, ranked first (http://www.the-dream-
project.org/result/classification-aml) among the best performers at the DREAM6 Molecular 
Classification of Acute Myeloid Leukemia Challenge. The description of the challenge can be found at 
http://www.the-dream-project.org/challenges/dream6flowcap2-molecular-classification-acute-
myeloid-leukaemia-challenge. 
 The approach uses relative entropies to evaluate if the distribution of the values of flow 
cytometry data for a given individual is closer to the overall distribution for AML or for Normal 
individuals in the space of values ! . Explicitly, the relative entropy difference 
 
!Si = Si,AML " Si,Normal = " Pi(#) ln[PNormal (#) / PAML(#)]d#$  indicates that the individual looks like an AML 
patient for positive values and like a Normal subject for negative values. 
 
Implementation:  
1. Compute the 4-dimensional histograms 
 
H (!)i, j,k  for the values of !=("FS Log", "SS Log", 
"FL3 Log",  j ) with  j !{"FL1 Log","FL2 Log", "FL4 Log","FL5 Log"} for Tube  k !
{1,2,3,4,5,6,7} for all individuals  i . For each individual there are  7 ! 4 = 28  histograms. 
2. Compute 
 
H (!)AML, j,k = H (!)i, j,ki"AML#  and  H (!)Normal , j,k = H (!)i, j,ki"Normal#  as the overall 
histograms for AML and Normal individuals. 
3. Normalize the histograms to obtain the probabilities 
 
P(!)i, j,k ,  
P(!)AML, j,k , and  
P(!)Normal , j,k . 
4. Compute the relative entropy differences 
 
!Si, j,k = " Pi, j,k (#) ln[PNormal , j,k (#) / PAML, j,k (#)]#$ . The 
total relative entropy difference is defined as 
 
!Si = !Si, j,kj,k"  . 
5. The likelihood that an individual  i  is AML positive is quantified as  Li = 1/ (1+ e
!"Si ) . 
 
Code execution: The data for the challenge are available at http://flowrepository.org/id/FR-FCM-
ZZYA. The two python files needed to execute the code are listed below. They can also be 
downloaded from http://www.ehu.es/biologiacomputacional/soft/. 
 In a directory of a Unix/OSX machine with the files "series10createdist_tot.py", 
"series10usedist_tot.py", "DREAM6AMLTrainingSet.csv", and the directory "CSV" with the files 
 2 
"0001.CSV", "0002.CSV"... execute:  
 
$ python -O -u series10createdist_tot.py ; python -O -u 
series10usedist_tot.py 
$ cat DREAM6_AML_Predictions_team21u.txt | sort -n -k 3 | cut -f 1,2 > 
DREAM6_AML_Predictions_team21.txt  
 
"series10createdist_tot.py" file: 
import csv 
from pylab import * 
import numpy 
 
 
GetNames= lambda y: ['CSV/%04d.CSV' % ((y-1)*8+i) for i in range(1,8)] 
ConR= lambda y: [log10(float(y[0])),float(y[1])]+[float(i) for i in y[2:]] 
ReadF= lambda y: [ConR(i) for i in [row for row in csv.reader(open(y,'rb'))][1:]] 
 
myranges=[arange(2.01,3.01,0.1)]+[arange(0.01,1.01,0.1) for i in range(6)] 
ibin=[[myranges[1],myranges[4],myranges[0],myranges[i]] for i in [2,3,5,6]] 
iex=[(1,4,0,i) for i in [2,3,5,6]] 
ll=len(ibin) 
 
def doSomething(xx, hh): 
 a=array(ReadF(xx)) 
 H=range(ll) 
 edges=range(ll) 
 for i in range(ll): 
  H[i], edges[i] = histogramdd(a[:,iex[i]], bins=ibin[i]) 
 return [H[i]+hh[i] for i in range(ll)] 
 
Tset=[row for row in csv.reader(open('DREAM6_AML_TrainingSet.csv','rb'))] 
 
AMLTs=[int(i[0]) for i in Tset if i[1]=='AML'] 
NormalTs=[int(i[0]) for i in Tset if i[1]=='Normal'] 
 
 
rr=range(7) 
 
H=[[zeros([len(i)-1 for i in ibin[k]]) for k in range(ll) ] for j in rr] 
for j in AMLTs[:]: 
 for i in rr:  
  print j 
  H[i]=doSomething(GetNames(j)[i], H[i]) 
  for k in range(ll): 
   numpy.save('hist_a_%d_%d.npy'% (i, k),H[i][k]) 
 
H=[[zeros([len(i)-1 for i in ibin[k]]) for k in range(ll) ] for j in rr] 
for j in NormalTs[:]: 
 for i in rr:  
  print j 
  H[i]=doSomething(GetNames(j)[i], H[i]) 
  for k in range(ll): 
   numpy.save('hist_n_%d_%d.npy'% (i, k),H[i][k]) 
 
"series10usedist_tot.py" file: 
import csv 
 3 
from pylab import * 
import numpy 
 
GetNames= lambda y: ['CSV/%04d.CSV' % ((y-1)*8+i) for i in range(1,8)] 
ConR= lambda y: [log10(float(y[0])),float(y[1])]+[float(i) for i in y[2:]] 
ReadF= lambda y: [ConR(i) for i in [row for row in csv.reader(open(y,'rb'))][1:]] 
 
myranges=[arange(2.01,3.01,0.1)]+[arange(0.01,1.01,0.1) for i in range(6)] 
ibin=[[myranges[1],myranges[4],myranges[0],myranges[i]] for i in [2,3,5,6]] 
iex=[(1,4,0,i) for i in [2,3,5,6]] 
ll=len(ibin) 
 
def doSomething(xx, hh1, hh2, yn=1): 
 a=array(ReadF(xx)) 
 H=range(ll) 
 edges=range(ll) 
 for i in range(ll): 
  H[i], edges[i] = histogramdd(a[:,iex[i]], bins=ibin[i]) 
 hh1=[hh1[i]-yn*H[i] for i in range(ll)] 
 epsi=[1e-10 for i in range(ll)] 
 peq1=[(epsi[i]+hh1[i])/sum(epsi[i]+hh1[i]) for i in range(ll)] 
 peq2=[(epsi[i]+hh2[i])/sum(epsi[i]+hh2[i]) for i in range(ll)] 
 pne=[(epsi[i]+H[i])/sum(epsi[i]+H[i]) for i in range(ll)] 
 slocal1=[pne[i]*log(pne[i]/peq1[i]) for i in range(ll)] 
 slocal2=[pne[i]*log(pne[i]/peq2[i]) for i in range(ll)] 
 return [sum(slocal1[i])-sum(slocal2[i]) for i in range(ll)] 
 
 
Tset=[row for row in csv.reader(open('DREAM6_AML_TrainingSet.csv','rb'))] 
 
AMLTs=[int(i[0]) for i in Tset if i[1]=='AML'] 
NormalTs=[int(i[0]) for i in Tset if i[1]=='Normal'] 
 
 
rr=range(7) 
 
Ha=[[numpy.load('hist_a_%d_%d.npy'%(j, i)) for i in range(ll)] for j in rr] 
Hn=[[numpy.load('hist_n_%d_%d.npy'%(j, i)) for i in range(ll)] for j in rr] 
 
for j in AMLTs[:]: 
 res=zeros(ll) 
 for i in rr:  
  rest=doSomething(GetNames(j)[i], Ha[i], Hn[i]) 
  print j, rest 
  res+=rest 
 print 0, sum(res), j, 9345677 
 
 
for j in NormalTs[:]: 
 res=zeros(ll) 
 for i in rr:  
  rest=doSomething(GetNames(j)[i], Hn[i], Ha[i]) 
  print j, [-i for i in rest] 
  res+=rest 
 print 1, -sum(res), j, 9345677 
 
f=open("./DREAM6_AML_Predictions_team21u.txt",'w') 
for j in range(180,360): 
 res=zeros(ll) 
 for i in rr: 
  rest=doSomething(GetNames(j)[i], Ha[i], Hn[i], 0) 
  print j, rest 
 4 
  res+=rest 
 print 2, sum(res), j, 9345677 
 f.write("%d\t%f\t%f\n" % (j,1/(1+exp(sum(res))), sum(res))) 
 f.flush() 
f.close() 
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Supplementary Figure 1: Interpopulation variability of AML and Normal cell populations. 
The two-dimensional distribution of cells with given values of the logarithms of the side scatter (SS 
log) and the marker CD45 (CD45 log) intensities are shown for all cell populations of the training set, 
with black and white colors representing high and zero densities, respectively. The label on the top of 
each graph indicates the patient number and the population type.   
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Supplementary Figure 2: Entropy-based discrimination between AML and Normal 
individuals. The total relative entropy difference, using equation (5) with  wk = 1, is shown for each 
individual of the training and test sets from one- to seven-dimensional landscapes. The likelihood that 
an individual of the test set is AML positive, given by equation (6), is also shown from one- to seven-
dimensional landscapes. Circles and squares represent, respectively, the actual AML and Normal state 
of a patient as clinically assessed by a physician. The insets are magnifications around the AML-
Normal boundary. 
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Supplementary Figure 3: Evolution of the segregation measure. The value of 
 
!! !S = wk!!S
k
k" , with  !!S
k = !Si=N min
k " !Si=Amax
k  ,   wk (t)  from equation (7), and  wk (0) = 1, is shown 
for the training set from one- to seven-dimensional landscapes. 
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Supplementary Figure 4: Weighted-entropy enhancement of the discrimination between 
AML and Normal individuals. Same situation as in Supplementary Figure 2 but with the weights wk
that maximize the distance  !! !S  of the training set excluding patient #116. 
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